Perfect Medical Health Management Limited (HKG:1830)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.420
-0.015 (-1.05%)
Aug 12, 2026, 4:08 PM HKT

HKG:1830 Cash Flow Statement

Millions HKD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
178.73206.9315.8315.64305.25
Depreciation & Amortization
153.23178.34201.96223.59219.05
Loss (Gain) From Sale of Assets
3.77-1.510.471.1-0.13
Loss (Gain) From Sale of Investments
----3.05
Stock-Based Compensation
1.813.441.34.244.58
Other Operating Activities
-3.1-22.13-7.344.8956.3
Change in Accounts Receivable
-1.7234.4-13.14-34.9963.21
Change in Inventory
8.72-7.522.46-3.04-3.07
Change in Accounts Payable
-11.79-2210.0417.33-34.29
Change in Unearned Revenue
-6.67-59.3510.2819.06-81.83
Change in Other Net Operating Assets
16.4922.3-24.7212.74-18.21
Operating Cash Flow
339.48332.88497.12560.57513.9
Operating Cash Flow Growth
1.98%-33.04%-11.32%9.08%-14.04%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-30.26-34.65-58.29-29.05-144.55
Sale of Property, Plant & Equipment
0.794.360.150.251.6
Investment in Securities
-152.21-142.94218.73-193.71151.87
Other Investing Activities
1.521.31.971.451.16
Investing Cash Flow
-180.16-171.93162.56-221.0610.07

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Repaid
-99.94-107.6-121.12-135.68-137.72
Net Debt Issued (Repaid)
-99.94-107.6-121.12-135.68-137.72
Issuance of Common Stock
---1515
Repurchase of Common Stock
---1.39-10.03-21.67
Common Dividends Paid
-162.05-359.27-391.93-191.79-405.48
Other Financing Activities
-7.95-11.08-6.53-12.52-16.1
Financing Cash Flow
-269.94-477.95-520.97-335.02-565.97

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
2.65-1.33-10.51-9.89-3.17
Net Cash Flow
-107.97-318.33128.21-5.41-45.17

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
309.22298.23438.84531.52369.34
Free Cash Flow Growth
3.69%-32.04%-17.44%43.91%-28.92%
Free Cash Flow Margin
32.13%26.44%31.50%38.26%27.36%
Free Cash Flow Per Share
0.250.240.350.430.30
Levered Free Cash Flow
254.19221.17362.89400.65322.01
Unlevered Free Cash Flow
259.16228.09369.9408.48332.07

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
7.9511.0811.2212.5216.1
Cash Income Tax Paid
44.4874.3186.3680.0630.23
Change in Working Capital
5.04-32.17-15.0811.11-74.19